Invention Grant
- Patent Title: Compounds alpha v beta 6 integrin antagonists
-
Application No.: US15514414Application Date: 2015-09-22
-
Publication No.: US10004724B2Publication Date: 2018-06-26
- Inventor: Niall Andrew Anderson , Matthew Howard James Campbell-Crawford , Ashley Paul Hancock , Seble Lemma , Simon John Fawcett MacDonald , John Martin Pritchard , Panayiotis Alexandrou Procopiou , Stephen Swanson
- Applicant: GlaxoSmithKline Intellectual Property Development Limited
- Applicant Address: GB Brentford, Middlesex
- Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee Address: GB Brentford, Middlesex
- Agent Jane F. Djung; Kathryn A. Lutomski
- Priority: GB1417018.7 20140926
- International Application: PCT/EP2015/071798 WO 20150922
- International Announcement: WO2016/046241 WO 20160331
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/4375 ; C07D207/04
Abstract:
A compound according to formula (I) wherein R1 is hydrogen, cyclopropyl, or pyrazolyl, wherein said pyrazolyl is optionally substituted by one or two methyl groups; or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20170290818A1 NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS Public/Granted day:2017-10-12
Information query
